(IN BRIEF) FinVector, a leading biopharmaceutical company, has inaugurated a cutting-edge production facility in Kuopio, Finland, aimed at manufacturing gene therapy products. The new Finport facility, which is set to become one of the world’s largest for such therapies, represents … Read the full press release →
Posted in Banks, Business, Environment, Financial, Finland, Government, Healthcare, Industrial, Infrastructure & Utilities, Investment, Management, News, Pharma & Biotech, Science, Technology
Tagged cancer treatment, FinVector, Gene Therapy Facility, Jean-Frédéric Paulsen, KUOPIO, NIB, partnership, Petri Peltonen, Professor Seppo Ylä-Herttuala, Soile Lahti, sustainability